Hormone Preparations Tied to Increased Bone Mineral Density in Postmenopausal Women
11 May 2023
Clinical Result
THURSDAY, May 11, 2023 -- Hormone preparations are associated with an increase in lumbar spine bone mineral density (BMD) in postmenopausal women, according to a study published online May 2 in Menopause.
Yiran Wang, M.D., and Chao Sun, M.D., from the First Affiliated Hospital of Xi'an Jiaotong University in China, evaluated the associations between hormone preparations with lumbar spine BMD, osteopenia, and osteoporosis in 6,031 postmenopausal women.
The researchers found a positive association between combined oral contraceptive pills, estrogen-only pills, estrogen/progestin combo pills, estrogen-only patches, or the use of more than two kinds of hormone preparations with lumbar spine BMD. Other hormone preparations also had a protective effect against osteopenia (all odds ratios less than 1.0), except for estrogen-only patches, but none of them were associated with osteoporosis prevalence. In the current and past users groups, BMD increased by 0.10 and 0.04 g/cm2, respectively, versus nonusers. The risk for osteopenia was reduced in both current and past user groups (odds ratios, 0.34 and 0.57, respectively).
"This large cross-sectional study showed that current and prior use of multiple types of hormone therapies, including combined hormone contraception used in premenopausal women and menopause hormone therapies, were linked with bone protection in postmenopausal women and that these effects persisted after discontinuation of treatment," Stephanie Faubion, M.D., medical director of the North American Menopause Society, said in a statement. "Additional study is needed to investigate the influence of time since stopping hormone therapy as well as the differential effects of various doses and formulations on bone health, including fracture risk."
Abstract/Full Text
Posted May 2023
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Targets
-Drugs
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.